New Advancements for Mitigating the Risk of Infections Associated with Central Venous Catheter
Central Venous Catheters are elongated, thin and flexible tubes that are placed in the veins in the neck, chest, groin or other veins in the arms. They are mostly used for managing and administering the medicines, blood, and nutrients and measuring central venous pressure (CVP), chemotherapy, and hemodialysis. Segmented into two types such as tunneled and non-tunneled, the central venous catheters can usually be placed in veins for a longer period of time than the other venous devices.
The tunneled central venous catheters are inserted hypodermically and its attachments are below the skin. With lateral exit sites and subcutaneously tunneling, they pose fewer risks of infection to the patients. Besides these, the non-tunneled catheters are inserted through the neck and chest with the help of percutaneous venipuncture insertion procedure. As they bulge out externally with an absence of subcutaneous tunneling there is a high risk of infection with the non-tunneled catheter.
With the growing number of risks associated with the central venous catheter, there is an exceeding requirement to tackle these problems. The growing product innovations and clinical advancements are a result of these requirements. The global market players in the central venous catheter market are determined towards implementing strategic actions with new products and increased distribution of the products to ensure effective stability in the market. With improved central venous catheter solutions, that help in tackle risks and reduce the complications faced by patients, the market players are on a constant move towards better and advanced venous devices such as the central venous catheter.
Risks associated with the procedure of catheterization
There are significant risks that are associated with the catheterization procedure. Complications such as damaged blood vessels, bleeding, puncture of arteries, blood-filled swelling and pneumothorax could be a result of central venous catheter insertion. Awareness regarding these complications and cognitive understanding towards the risks associated with the central venous catheterization could result in decreasing willingness towards the implementation of the procedure and adversely cause a hindrance in the growth of the central venous catheter market to a certain extent. With the growing concerns of risks, medical and clinical device manufacturers and particularly, the central venous catheter manufacturers are striving towards introducing improved and technologically-advanced products in the market, which could offer opportunities of minimizing complications and risks associated with the catheterization procedures.
Antimicrobial coated catheter for remediating risk of infections
With the growing concerns for better and improved central venous catheter solutions, there was a significant rise in the use of the antimicrobial coated central venous catheter. With the substantial elimination of the major risks related to prominent infections such as Cather Related Blood Stream Infections (CRBSI) and Catheter Related Urinary Tract Infections (CAUTI) antimicrobial coated catheter proved to be a ground-breaking advancement in the central venous catheter market. With antimicrobial and antithrombotic coated catheter introduced to the market, there were relatively low risks visible in the process of catheterization providing large opportunities to the key players of the central venous catheter market.
3M Korea to introduce their all-in-one catheter securing system
The new system introduced by 3M Korea for centralized catheter anchoring is a revolutionary solution to help tackle the risks of the bloodstream infection associated with the central venous catheter system. This package system, called as PICC/CVC securement device+ CHG Dressing is well-equipped and can fasten a central venous catheter (CVC) and a peripherally inserted central catheter (PICC) without stitching the skin.
With conventional skin sutures, the patients experience pain and discomfort with the central venous catheter tubes affixed to the skin by stitches. Risk of infection around the sutured skin and stab injuries by medical professionals were major challenges that needed to be tackled. With devices that require no stitches pose fewer incidents of risk and help in providing better medical treatment to the patients. Their PICC/CVC securing device called Tegaderm is uniquely designed for providing such treatment to the patients and ensuring a safe and secure environment for the same. This device reduces the risk of several infections resulted from the insertion of the central venous catheter.
With continuous efforts taken towards providing innovative products and perpetual actions for delivering improved medical devices and supplies for advanced ICU treatment, 3M is constantly heading towards product innovations.
Central venous catheter market witnessed rapid expansion with the increasing significance attained by tip location devices for precise placement of the central venous catheter. Along with technological advancements, the increasing chronic diseases and the prevalence of malignant disease cancer boosted the central venous catheter market.